Charleston, SC -- (SBWIRE) -- 10/18/2013 -- otcstockcenter.com, provide information specifically for trades in the micro cap market. Micro caps are companies with a capitalization between $50 million and $300 million. We provide the information active traders need, when they need it. By combining our research capabilities with our instant alerts, subscribers are able to better determine trading strategies and execute those strategies faster. Lets have a look on Few Hot Stocks, B2Gold Corp(NYSEMKT:BTG), Compania de Minas Buenaventura SAA(NYSE:BVN), Biozone Pharmaceuticals Inc(OTCBB:BZNE), Core Laboratories N.V.(NYSE:CLB)
B2Gold Corp(NYSEMKT:BTG) closed latest trading day at $2.37, up +9.22%, on volume of over 1.75 million shares. The stock fell -8.24% in the last 5 days. Its average trading volume is 2.93 million shares. Its market capitalization was $1.41 billion. B2Gold Corp. engages in the exploration and development of mineral properties in Nicaragua, Colombia, Namibia, and Uruguay.
What was the Moving Force behind BTG On Bullish Run? Read This Research Report on BTG
With the latest rise of +10.25%, Compania de Minas Buenaventura SAA(NYSE:BVN) now has YTD performance -61.22% which for the week is positive at 18.85%. The total number of shares traded on the latest trading day was about 6.11 million shares, and changed hands at price range of $12.92 to $14.15 apiece. The company ended previous trading at $12.58. Compañía de Minas Buenaventura S.A.A., a precious metals company, engages in the exploration, mining, and processing of gold and silver in Peru.
For How Long BVN will Fight for Profitability? Read This Trend Analysis report
Biozone Pharmaceuticals Inc(OTCBB:BZNE) reported the price of the stock moved up +22.86% and finished the day at $0.860 on above average volume. The total number of shares traded on the latest trading day was about 3.29 million shares, and changed hands at price range of $0.71 to $0.97 apiece. The shares declined about -71.33% since the start of year and has at 75.51% gain in last three months. Narrowing down the performance period, the stock rose 24.64% for the month and at 77.32% gain over the week. Biozone Pharmaceuticals, Inc., through its subsidiaries, engages in developing and manufacturing over the counter (OTC) drug products, and cosmetic and beauty products on behalf of third parties in the United States and internationally.
For How Long BZNE’s Gloss will Attract Investors ? Find out via this report
Core Laboratories N.V.(NYSE:CLB) ended previous trading at $174.91, gaining +8.54%.The total number of shares traded on the latest trading day was about 1.09 million shares. In the last 5 days it showed a recovery of 7.97% and on its one month graph, shares are 15.63% up. The stock has a 52-week high price of $192.94 and its 52-week low was recorded at $94.72. Core Laboratories N.V. provides reservoir description, production enhancement, and reservoir management services to the oil and gas industry worldwide.
Will CLB Continue To Move Higher? Find Out Here
About OTC Stock Center
We provide the information active traders need, when they need it. By combining our research capabilities with our instant alerts, subscribers are able to better determine trading strategies and execute those strategies faster. More trades can mean more profits to those who can take advantage of the picks included with our service. We provide high quality picks in a timely fashion so that you are free to do what you do best, which is trade for profit. Alertness.
Markets move on information. Our subscribers get our picks fast and first by signing up for our email and text alerts. This information is exclusively for our readers, but once it’s out, the markets move and move fast. Getting the right information is always important, getting it first and in time to be able to build your trades is even more important. Don’t miss out on the chance to take your trading to the next level.
OTC Stock Center’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by OTC Stock Center or an offer or solicitation to buy or sell any security. Neither the owner of OTC Stock Center nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases.
Please read Our Full Disclaimer at: http://otcstockcenter.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)